Abstract
The role of immunological phenotype in childhood acute lymphoblastic leukemia’s (ALL) is important in classifying the different origins of ALL, but the identification of different subgroups of clinical relevance is still under discussion. In fact, frequent discrepancies are observed in the prognostic value of immunological subgroups in individual series. A poor outcome was seen in immunophenotype T in the first clinical studies (Greaves et al. 1981), but these results have not always been confirmed and now the T origin of ALL is not considered a prognostic factor (Hammond et al. 1986).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Basso G, Capuzzo F, Simioni E et al (1985) Immunocytochemical evidence of common ALL antigen in null ALL. Scand J Haematol 35: 536–542
Basso G, Putti MC, Cantii-Rajnoldi A et al (1992) The immunophenotype in infant acute lymphoblastic leukaemia: correlation with clinical outcome. An italian multicentre study ( AIEOP ). Br J Haematol 81: 184–191
Bennett JM, Catovsky D, Daniel MT et al (1976) Proposals for the classification of the acute leukemias. Br J Haematol 33: 451–458
Crist W, Boyett J, Jackson J et al (1989) Prognostic importance of the pre-B-cell immunophenotype and other presenting features in B-lineage childhood acute lymphoblastic leukemia. A Pediatric Oncology Group Study. Blood 74: 1252–1259
Crist WM, Carroll AJ, Shuster JJ et al (1990) Poor prognosis of children with pre- B acute lymphoblastic leukemia in children: their relationship to presentation features and prognosis. Br J Haematol 48: 179–197
Greaves MF, Janossy G, Peto J, Kay H (1981) Immunologically defined subclasses of acute lymphoblastic leukemia in children: their relationship to presentation features and prognosis. Br J Haematol 48: 179–197
Hammond D, Sather H, Nesbit M et al (1986) Analysis of prognostic factors in acute lymphoblastic leukemia. Med Ped Oncol 19: 28–32
Henze G, Fegler R, Reiter A et al (1990) Impact of early intensive reinduction therapy on event-free survival in children with low-risk acute lymphoblastic leukemia. Haematol Blood Transfusion 2: 483–488
Ludwig WD, Seibt-Jung H, Teichmann JV et al (1989a) Clinicopathologic features and prognostic implications of immunophenotypic subgroups in childhood ALL: experience of the BFM-ALL study 83. In: Neth R, Gallo RC, Greaves MF, Gaedicke G, Gohla S, Mannweiler K, Ritter J (eds) Modern Trends in Human Leukemia VIII. Springer, Berlin Heidelberg New York, pp 51–57 (Haematology and blood transfusion, vol 32 )
Ludwig WD, Bartram CR, Harbott J et al (1989b) Phenotypic and genotypic heterogeneity in infant acute leukemia I. Acute lymphoblastic leukemia. Leukemia 6: 431–439
Miller DR, Coccia PF, Bleyer WA et al (1989) Early response to induction therapy as a predictor of disease-free survival from Children Cancer Study Group. J Clin Oncol 7: 1807–1815
Nadler LM, Korsmeyer SJ, Anderson KC et al (1984) B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation. J Clin Invest 74: 332–340
Rossi MR, Valsecchi MG, Testi AM et al (1991) Preliminary report on AIEOP protocol 88 for childhood acute lymphoblastic leukemia (ALL). Haematologica 76 [Suppl 4]: 174 (abstr)
Schrappe M, Beck J, Brandeis WE et al (1987a) Die Behandlung der akuten lymphoblastischen Leukaemie im Kindes- und Jugendalter: Ergebnisse der multizentrischen Therapiestudie ALL-BFM81. Klin Paediatr 199: 133–150
Schrappe M, Henze G, Ludwig R et al (1987b) The in vivo corticosteroid response and its prediction for early therapy failure in childhood ALL: a report from the BFM study group. Fourth International Symposium on Therapy of Acute Leukemias. Rome, February 1987, p 167
Sen L, Borella L (1975) Clinical importance of lymphoblast with T markers in childhood acute leukemia. N Engl J Med 292: 828
Sobol RE, Mick R, Royston I et al (1987) Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. N Engl J Med 316: 1111–1117
Steinherz PG, Gaynon P, Miller DR et al (1986) Improved disease free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen — a new intensive therapy protocol: a report from the CCSG. J Clin Oncol 4: 744–752
Vecchi V, Rondelli R, Rosati D et al (1991) 87-AIEOP protocol for non-B newly diagnosed childhood acute lymphoblastic leukemia. Haematologica 76 [Suppl 4]: 178 (abstr)
Zaki SR, Austin GE, Swan D et al (1989) Human myeloperoxidase gene expression in acute leukemia. Blood 6: 2096–2102
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Basso, G. et al. (1993). Incidence and Prognostic Significance of Immunophenotypic Subgroups in Childhood Acute Lymphoblastic Leukemia: The Experience of the AIEOP Cooperative Study. In: Ludwig, WD., Thiel, E. (eds) Recent Advances in Cell Biology of Acute Leukemia. Recent Results in Cancer Research, vol 131. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84895-7_26
Download citation
DOI: https://doi.org/10.1007/978-3-642-84895-7_26
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-84897-1
Online ISBN: 978-3-642-84895-7
eBook Packages: Springer Book Archive